Keurig Dr Pepper Inc. 8-K Report: Key Insights on August 15, 2025 Event

$KDP
Form 8-K
Filed on: 2025-08-15
Source
Keurig Dr Pepper Inc. 8-K Report: Key Insights on August 15, 2025 Event

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Keurig Dr Pepper Inc.
  • CIK Code: 0001418135
  • Location: 53 South Avenue, Burlington, MA 01803
  • Contact Number: 877-208-9991
  1. SEC Filing Details:
  • Filing Type: 8-K (a current report used to disclose major events that shareholders should know about)
  • Filing Date: August 15, 2025
  • SEC Central Index Key (CIK): 0001418135
  • File Number: 001-33829
  • Employer Identification Number (EIN): 98-0517725
  1. Reporting Period:
  • Report Date: August 15, 2025 (the start date and end date of the reporting period are the same, indicating a specific event or transaction reported on that date).
  1. Stock Information:
  • Stock Type: Common Stock
  • Ticker Symbol: KDP
  • Stock Exchange: NASDAQ
  1. Units of Measurement:
  • The report uses USD (U.S. Dollars) for financial measures and shares for stock metrics.
  • There is a reference to USD per share, indicating a financial metric that may be discussed in the full report.

Insights:

  • The filing indicates that Keurig Dr Pepper Inc. has reported a significant event on August 15, 2025, which is typical for an 8-K filing. Shareholders would benefit from reviewing this report for any strategic moves, financial results, or changes in management.
  • The presence of a specific date for the reporting period suggests that this filing may contain time-sensitive information or recent developments that could influence investor sentiment.
  • This filing is essential for investors tracking performance and developments associated with KDP, especially given its public trading status on NASDAQ.

Overall, stakeholders should examine this 8-K report for detailed information about events occurring on the specified date that could impact the company’s financial health or operational direction.